AAFM Dermatology Practice Test 2026 – Complete Exam Prep

Methotrexate is regarded as the gold standard for treating severe disabling arthritis associated with psoriasis due to its robust efficacy and established safety profile. It works as a disease-modifying antirheumatic drug (DMARD) that not only helps in managing psoriatic arthritis symptoms but also contributes to controlling the underlying psoriasis. Methotrexate has a long history of use, and clinical studies have consistently shown its ability to improve joint function and reduce the progression of joint damage in patients with psoriatic arthritis.

Additionally, its oral formulation is often preferred in clinical settings, and it can be appropriately monitored for potential side effects, making it a practical choice for long-term management. The drug’s ability to address both skin and joint manifestations makes it especially valuable for patients suffering from both psoriasis and associated arthritic conditions. This dual efficacy, along with its acceptability in clinical practice, solidifies its status as the first-line treatment for severe cases.